Established
in 1945, Daewoong Pharmaceutical
Co., Ltd. has the largest prescription
drug sales in Korea and envisions
itself to become a top 50 global
healthcare company by 2010. Daewoong
has maintained a steady growth
rate in the double digits and
has paid surplus dividends for
the last 40 years.
In addition to its product portfolio,
which includes 10 blockbuster
products, Daewoong has built strong
core competency for new drug development
and has cultivated a cooperative
culture for collaboration with
global partners.
In the future, Daewoong will expand
its global business with its foreign
branches and global partners and
become a global healthcare group
which contributes to improving
the quality of life for people
worldwide. |
|
 |
|
| Stock
Exchange Listing |
: KSE069620 |
|
| Market
Capitalization |
: 667 million (Mar.2007, USD) |
|
| Employees |
: 1,200 |
|
| Sales |
: 425 million (Mar.2007, USD) |
|
| Branches |
: 10 (Korea) 5 (Asia) |
|
|
 |
|
 |
|
 |
|
|
